New patent for Am Regent drug MULTRYS

   November 16, 2023    Comments Off on New patent for Am Regent drug MULTRYS    Posted in: Patent Added

Annual Drug Patent Expirations for MULTRYS Multrys is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. The generic ingredient in…

The post New patent for Am Regent drug MULTRYS appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog